Perfil
Aaron Tward is the founder of Affinia Therapeutics, Inc., founded in 2019.
Dr. Tward currently holds the positions of Associate Professor at The University of California, San Francisco since 2022 and Chief Scientific Officer at Akouos, Inc. since 2022.
Dr. Tward earned a doctorate degree from The University of California, San Francisco.
Cargos activos de Aaron Tward
| Empresas | Cargo | Inicio |
|---|---|---|
| AKOUOS | Director Técnico/Científico/I+D | 10/03/2022 |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/03/2022 |
Antiguos cargos conocidos de Aaron Tward.
| Empresas | Cargo | Fin |
|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Fundador | - |
Formación de Aaron Tward.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
- Bolsa de valores
- Insiders
- Aaron Tward
















